Global Implantable Cardioverter Defibrillator (ICD) Market - Forecasts from 2018 to 2023

March 2018 | 88 pages | ID: G4586008C29EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global implantable cardioverter defibrillators market was valued at US$7.615 billion in 2017 and is projected to expand at a CAGR of 6.17% over the forecast period to reach US$10.904 billion by 2023. Rapidly increasing geriatric population in many regions across the globe is a major factor responsible for the growth of ICD market. Rising incidence of sudden cardiac arrests due to ventricular arrhythmia or any other reason is spurring the demand for advanced ICDs which can keep a track of the patient’s heartbeat and restore normal heartbeat when an abnormal beating is detected. Continuous improvements in technology are increasing the efficiency and reliability of these ICDs, thereby bolstering their adoption by the end-users.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the implantable cardioverter defibrillators value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global implantable cardioverter defibrillators market.

Major industry players profiled as part of the report are Boston Scientific Corporation, Abbot, and Medtronic among others.

SEGMENTATION

The global implantable cardioverter defibrillators market has been analyzed through following segments:

• By Chamber
• Single Chambered
• Dual Chambered
• By Type
• Subcutaneous ICD
• Transvenous ICD
• Cardiac Resynchronization Therapy Defibrillator
• By End User
• Hospitals & Clinics
• Ambulatory Care Centre
• By Geography
• North America
• United States
• Canada
• Mexico
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• Italy
• United Kingdom
• Others
• Middle East and Africa
• Israel
• Saudi Arabia
• South Africa
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Product Pipeline
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET BY CHAMBER

5.1. Single Chambered
5.2. Dual Chambered

6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET BY TYPE

6.1. Subcutaneous ICD
6.2. Transvenous ICD
6.3. Cardiac Resynchronization Therapy Defibrillator

7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET BY END USER

7.1. Hospitals & Clinics
7.2. Ambulatory Care Centre

8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. United States
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. Italy
  8.3.4. United Kingdom
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Israel
  8.4.2. Saudi Arabia
  8.4.3. South Africa
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. Japan
  8.5.2. China
  8.5.3. India
  8.5.4. Australia
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Recent Deals and Investment
9.2. Strategies of Key Players
9.3. Investment Analysis

10. COMPANY PROFILES

10.1. Boston Scientific Corporation
  10.1.1. Company Overview
  10.1.2. Financials
  10.1.3. Products and Services
  10.1.4. Recent Developments
10.2. Medtronic
  10.2.1. Company Overview
  10.2.2. Financials
  10.2.3. Products and Services
  10.2.4. Recent Developments
10.3. MicroPort Scientific Corporation
  10.3.1. Company Overview
  10.3.2. Financials
  10.3.3. Products and Services
  10.3.4. Recent Developments
10.4. LivaNova PLC
  10.4.1. Company Overview
  10.4.2. Financials
  10.4.3. Products and Services
  10.4.4. Recent Developments
10.5. Abbot
  10.5.1. Company Overview
  10.5.2. Financials
  10.5.3. Products and Services
  10.5.4. Recent Developments
  10.5.5. Developments